<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>PCP - Complete Profile</title>
    <link rel="stylesheet" href="/Dyo-s-Dubious-Domain/style.css">
    <script>
        // Set base path for JavaScript files to use
        window.SITE_BASE_PATH = '/Dyo-s-Dubious-Domain/';
    </script>
</head>

<body class="
  
  
  
  ">
    <header class="page-header">
  <div class="container">
    <div class="page-header__content">
      <div class="logo-container">
        <a href="/Dyo-s-Dubious-Domain/" class="site-title">Dyo's Dubious Domain</a>
      </div>
      
      <nav>
        <ul role="list" class="nav-list flex-group">
          <li>
            <a href="/Dyo-s-Dubious-Domain/">Home</a>
          </li>
          <li>
            <a href="/Dyo-s-Dubious-Domain/dyos-domain/">Dyo's Domain</a>
          </li>
          <li>
            <a href="/Dyo-s-Dubious-Domain/about/">About</a>
          </li>
          <li>
            <a href="/Dyo-s-Dubious-Domain/profile/">My Profile</a>
          </li>
         
        </ul>
      </nav>
    </div>
    
    <!-- Search Bar - Now underneath header -->
    <div class="search-container">
      <input type="text" id="search-input" placeholder="Search substances..." class="search-input" />
      <div id="search-results" class="search-results" style="display: none;"></div>
    </div>
  </div>
</header>

    <main>
      
<div class="substance-profile-header">
  <div class="container">
    <nav class="breadcrumb">
      <a href="/dyos-domain/">Dyo's Domain</a> ‚Üí <a href="/dyos-domain/dissociatives/">Dissociatives</a> ‚Üí <span>PCP</span>
    </nav>
    
    <div class="substance-hero">
      <div class="substance-info">
        <h1>üëπ PCP</h1>
        <h2 class="chemical-name">1-(1-phenylcyclohexyl)piperidine</h2>
          <!-- Add to Profile Button -->
        <button id="add-to-profile-btn" class="add-to-profile-btn not-in-profile" 
                data-substance="PCP" 
                data-category="Dissociatives" 
                data-chemical="1-(1-phenylcyclohexyl)piperidine">
          + Add to My Profile
        </button>
        
        <div class="alternative-names">
          <h3>Alternative Names & Slang</h3>
          <div class="names-grid">
            <div class="name-category">
              <h4>Common Names</h4>
              <span>Angel Dust</span> ‚Ä¢ <span>Phencyclidine</span> ‚Ä¢ <span>Peace Pill</span> ‚Ä¢ <span>Lovely</span> ‚Ä¢ <span>Hog</span>
            </div>
            <div class="name-category">
              <h4>Street Names</h4>
              <span>Dust</span> ‚Ä¢ <span>Wet</span> ‚Ä¢ <span>Embalming Fluid</span> ‚Ä¢ <span>Rocket Fuel</span> ‚Ä¢ <span>Zombie Drug</span>
            </div>
            <div class="name-category">
              <h4>Combination Names</h4>
              <span>Sherm</span> ‚Ä¢ <span>Fry</span> ‚Ä¢ <span>Illy</span> ‚Ä¢ <span>Water</span> ‚Ä¢ <span>Amp</span>
            </div>
            <div class="name-category">
              <h4>Chemical/Medical</h4>
              <span>Phencyclidine Hydrochloride</span> ‚Ä¢ <span>Sernyl</span> ‚Ä¢ <span>Sernylan</span> ‚Ä¢ <span>CI-395</span>
            </div>
          </div>
        </div>
        
        <div class="substance-meta-large">
          <span class="category dissociative-anesthetic">Dissociative Anesthetic</span>
          <span class="legal-status schedule-2">Schedule II</span>
          <span class="duration long">4-8 hours</span>
        </div>
      </div>
      
      <div class="substance-visual">
        <div class="substance-image">
          <img src="/assets/substances/pcp.jpg" alt="PCP powder, liquid preparations, and cigarettes dipped in PCP solution showing the various forms of angel dust consumption" class="substance-photo">
        </div>
        <div class="molecule-structure">
          <div class="structure-placeholder">
            <p>üß¨ C‚ÇÅ‚ÇáH‚ÇÇ‚ÇÖN</p>
            <p>MW: 243.39 g/mol</p>
          </div>
        </div>
      </div>
    </div>
  </div>
</div>

<div class="container">
  
  <div class="profile-grid">
    
    <div class="profile-section identification">
      <h3>üîç Physical Identification</h3>
      <div class="identification-info">
        <div class="pure-form">
          <h4>Pure PCP (Hydrochloride Salt)</h4>
          <ul>
            <li><strong>Appearance:</strong> White crystalline powder (pure form)</li>
            <li><strong>Texture:</strong> Fine to coarse crystalline material</li>
            <li><strong>Odor:</strong> Distinctive chemical smell, sometimes described as "ether-like"</li>
            <li><strong>Taste:</strong> Bitter, metallic, numbing sensation</li>
            <li><strong>Solubility:</strong> Readily soluble in water, alcohol, and oils</li>
            <li><strong>Color variations:</strong> Can range from white to tan to brown depending on purity</li>
          </ul>
        </div>
        
        <div class="street-forms">
          <h4>Street Forms & Preparations</h4>
          <ul>
            <li><strong>Powder form:</strong> White to brown powder, often mixed with adulterants</li>
            <li><strong>Liquid preparations:</strong> Clear to colored liquid for dipping cigarettes</li>
            <li><strong>"Sherm" cigarettes:</strong> Tobacco or marijuana cigarettes dipped in PCP solution</li>
            <li><strong>Pills/tablets:</strong> Sometimes pressed into tablet form (rare)</li>
            <li><strong>Crystal form:</strong> Large chunky crystals (less common on street)</li>
            <li><strong>Joints/blunts:</strong> Cannabis mixed with PCP powder or soaked in liquid</li>
          </ul>
        </div>
        
        <div class="adulterants-warning">
          <h4>‚ö†Ô∏è Common Adulterants & Misrepresentations</h4>
          <p><strong>"Embalming fluid" myth:</strong> Street "wet" is PCP solution, not actual embalming fluid</p>
          <p><strong>Adulterants:</strong> Lactose, mannitol, inositol, caffeine, lidocaine</p>
          <p><strong>Misrepresented as:</strong> THC liquid, synthetic cannabinoids, other dissociatives</p>
          <p><strong>Contamination:</strong> Synthesis byproducts can be highly toxic</p>
          <p><strong>Potency variation:</strong> Street preparations vary wildly in concentration</p>
        </div>
      </div>
    </div>
    
    <div class="profile-section dosage">
      <h3>üíä Dosage Guidelines</h3>
      <div class="dosage-chart">
        <div class="dose-range threshold">
          <span class="range-label">Threshold</span>
          <span class="dose-amount">1-3mg</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range light">
          <span class="range-label">Light</span>
          <span class="dose-amount">3-5mg</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range common">
          <span class="range-label">Common</span>
          <span class="dose-amount">5-10mg</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range strong">
          <span class="range-label">Strong</span>
          <span class="dose-amount">10-15mg</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range heavy">
          <span class="range-label">Heavy</span>
          <span class="dose-amount">15mg+</span>
          <div class="dose-bar"></div>
        </div>
      </div>
      
      <div class="dosage-details">
        <h4>‚ö†Ô∏è EXTREME DOSAGE WARNINGS</h4>
        <ul>
          <li><strong>Extremely potent:</strong> Active doses measured in single milligrams</li>
          <li><strong>No safe recreational dose:</strong> Therapeutic window extremely narrow</li>
          <li><strong>Unpredictable street concentrations:</strong> "Wet" preparations vary 100-fold in potency</li>
          <li><strong>Overdose threshold:</strong> >20mg can cause coma, seizures, death</li>
          <li><strong>Route sensitivity:</strong> Smoking/injection much more dangerous than oral</li>
        </ul>
        
        <h4>Historical Medical Dosing (Discontinued)</h4>
        <ul>
          <li><strong>Human anesthesia (1950s-1960s):</strong> 0.25-0.5mg/kg IV (discontinued due to emergence reactions)</li>
          <li><strong>Veterinary anesthesia:</strong> 1-2mg/kg IM (still used in some applications)</li>
          <li><strong>Research doses:</strong> 0.05-0.1mg/kg for controlled studies</li>
          <li><strong>Psychotomimetic research:</strong> 0.1-0.25mg/kg (produced severe adverse effects)</li>
        </ul>
        
        <h4>üö® Street Use Reality</h4>
        <ul>
          <li><strong>Impossible dose control:</strong> Street preparations have unknown concentrations</li>
          <li><strong>Accidental overdoses common:</strong> Users cannot predict effects from street preparations</li>
          <li><strong>Emergency room standard:</strong> PCP overdose assumed until proven otherwise</li>
          <li><strong>No antidote available:</strong> Only supportive care for overdose situations</li>
          <li><strong>Prolonged effects:</strong> Can last 8+ hours with single use</li>
        </ul>
      </div>
      
      <p class="dosage-note"><strong>CRITICAL WARNING:</strong> PCP has no safe recreational dosage. Street preparations make accurate dosing impossible, leading to frequent emergencies.</p>
    </div>

    <div class="profile-section effects">
      <h3>‚ú® Effects Profile</h3>
      
      <div class="effects-timeline">
        <h4>Timeline (Smoked)</h4>
        <div class="timeline-item">
          <span class="time">T+0:02-0:05</span>
          <span class="effect">Onset - immediate dissociation and numbness</span>
        </div>
        <div class="timeline-item">
          <span class="time">T+0:15-2:00</span>
          <span class="effect">Peak - complete dissociation, potential agitation</span>
        </div>
        <div class="timeline-item">
          <span class="time">T+2:00-6:00</span>
          <span class="effect">Plateau - continued dissociation, confusion</span>
        </div>
        <div class="timeline-item">
          <span class="time">T+6:00-24:00</span>
          <span class="effect">Comedown - gradual return, possible psychosis</span>
        </div>
      </div>

      <div class="effects-categories">
        <div class="effect-category dissociative">
          <h4>üåÄ Dissociative Effects</h4>
          <ul>
            <li>Complete dissociation from body and environment</li>
            <li>Profound anesthesia and numbness</li>
            <li>Ego dissolution and depersonalization</li>
            <li>Time distortion and memory impairment</li>
            <li>Out-of-body experiences</li>
            <li>Complete loss of pain sensation</li>
          </ul>
        </div>
        
        <div class="effect-category behavioral">
          <h4>üéØ Behavioral Effects</h4>
          <ul>
            <li>Extreme unpredictability</li>
            <li>Potential for violent or bizarre behavior</li>
            <li>Superhuman strength perception (myth)</li>
            <li>Complete loss of social inhibition</li>
            <li>Inability to assess danger or consequences</li>
            <li>Cataleptic states or catatonia</li>
          </ul>
        </div>
        
        <div class="effect-category dangerous">
          <h4>‚ùå Dangerous Effects</h4>
          <ul>
            <li>Severe agitation and combativeness</li>
            <li>Hyperthermia and cardiovascular stress</li>
            <li>Respiratory depression at high doses</li>
            <li>Seizures and convulsions</li>
            <li>Psychotic episodes lasting days</li>
            <li>Self-harm due to anesthesia</li>
            <li>Permanent psychological damage</li>
          </ul>
        </div>
      </div>
    </div>

    <div class="profile-section pharmacology">
      <h3>üß† Pharmacology & Neuroscience</h3>
      <div class="pharma-details">
        <h4>Primary Mechanism of Action</h4>
        <p>PCP is a non-competitive NMDA receptor antagonist that blocks the ion channel activated by glutamate and glycine. This disrupts normal excitatory neurotransmission throughout the brain, particularly in areas responsible for consciousness, pain perception, and reality testing. The resulting glutamate system dysfunction creates profound dissociation and can trigger psychotic symptoms by disrupting the brain's ability to process sensory information and maintain coherent thought patterns.</p>
        
        <h4>Detailed Receptor Pharmacology</h4>
        <div class="receptor-table">
          <div class="receptor-row">
            <span class="receptor-name"><strong>NMDA receptor</strong></span>
            <span class="affinity">High affinity (Ki: ~59 nM)</span>
            <span class="function">Primary dissociative effects, anesthesia, psychotomimetic effects</span>
          </div>
          <div class="receptor-row">
            <span class="receptor-name"><strong>Dopamine transporter (DAT)</strong></span>
            <span class="affinity">Moderate affinity (~1000 nM)</span>
            <span class="function">Stimulant effects, reward activation, potential psychosis</span>
          </div>
          <div class="receptor-row">
            <span class="receptor-name"><strong>Serotonin transporter (SERT)</strong></span>
            <span class="affinity">Moderate affinity (~500 nM)</span>
            <span class="function">Serotonergic effects, mood alteration</span>
          </div>
          <div class="receptor-row">
            <span class="receptor-name"><strong>œÉ1 receptor</strong></span>
            <span class="affinity">High affinity (~100 nM)</span>
            <span class="function">Contributes to psychotomimetic effects</span>
          </div>
          <div class="receptor-row">
            <span class="receptor-name"><strong>Nicotinic receptors</strong></span>
            <span class="affinity">Moderate antagonist activity</span>
            <span class="function">Additional anesthetic effects</span>
          </div>
        </div>

        <h4>Metabolism & Pharmacokinetics</h4>
        <div class="metabolism-details">
          <p><strong>Primary Pathway:</strong> Hydroxylation and glucuronidation in liver</p>
          <p><strong>Active Metabolites:</strong> Several metabolites retain activity</p>
          <p><strong>Half-life:</strong> 17-25 hours (extremely long for acute effects)</p>
          <p><strong>Bioavailability:</strong> ~70% oral, near 100% smoked/injected</p>
          <p><strong>Peak plasma:</strong> 2-5 minutes (smoked), 1-2 hours (oral)</p>
          <p><strong>Protein binding:</strong> ~65%, allowing significant brain penetration</p>
          <p><strong>Elimination:</strong> Slow, with effects persisting long after peak plasma levels</p>
        </div>

        <h4>Neurotoxicity and Brain Changes</h4>
        <div class="neurotoxicity-info">
          <p><strong>Glutamate system damage:</strong> Chronic use damages NMDA receptors and glutamate neurons</p>
          <p><strong>White matter changes:</strong> Documented brain structural changes with repeated use</p>
          <p><strong>Cognitive impairment:</strong> Persistent memory, attention, and executive function deficits</p>
          <p><strong>Schizophrenia model:</strong> PCP intoxication closely mimics acute schizophrenia symptoms</p>
          <p><strong>Irreversible changes:</strong> Some brain changes may be permanent with chronic use</p>
        </div>

        <h4>Unique Pharmacological Properties</h4>
        <ul>
          <li><strong>Multi-target activity:</strong> Affects multiple neurotransmitter systems simultaneously</li>
          <li><strong>Biphasic effects:</strong> Stimulant at low doses, depressant at high doses</li>
          <li><strong>Long duration:</strong> Effects persist far longer than plasma levels suggest</li>
          <li><strong>Tolerance paradox:</strong> Some effects show tolerance, others show sensitization</li>
          <li><strong>Psychosis induction:</strong> Can trigger lasting psychotic episodes in vulnerable individuals</li>
        </ul>
      </div>
    </div>

    <div class="profile-section safety">
      <h3>‚ö†Ô∏è Safety & Harm Reduction</h3>
      
      <div class="safety-grid">
        <div class="safety-item critical">
          <h4>üö® EXTREME DANGER</h4>
          <ul>
            <li><strong>No safe recreational use:</strong> Therapeutic window too narrow for non-medical use</li>
            <li><strong>Unpredictable violence:</strong> Can trigger dangerous, uncontrollable behavior</li>
            <li><strong>Complete anesthesia:</strong> Cannot feel pain, leading to severe self-injury</li>
            <li><strong>Psychotic episodes:</strong> Can trigger lasting mental health crises</li>
            <li><strong>Emergency overdoses:</strong> Frequent cause of emergency room visits</li>
          </ul>
        </div>
        
        <div class="safety-item precautions">
          <h4>üõ°Ô∏è If Use Occurs (Harm Reduction)</h4>
          <ul>
            <li>NEVER use alone - have multiple sober observers present</li>
            <li>Remove all dangerous objects from environment</li>
            <li>Prepare for 8+ hour duration of effects</li>
            <li>Have emergency contacts and transport ready</li>
            <li>Understand that you cannot "talk down" someone on PCP</li>
            <li>Prepare for possible police/EMS involvement</li>
            <li>Know signs of hyperthermia and respiratory depression</li>
          </ul>
        </div>
      </div>

      <div class="superhuman-strength-myth">
        <h4>üí™ "Superhuman Strength" Myth Debunked</h4>
        <p><strong>Urban legend:</strong> PCP does not grant actual superhuman strength. <strong>Medical reality:</strong> Complete anesthesia removes pain feedback that normally limits exertion. <strong>Injury mechanism:</strong> Users injure themselves and others by ignoring pain signals. <strong>Law enforcement training:</strong> Multiple officers needed due to pain insensitivity, not increased strength.</p>
      </div>

      <div class="emergency-response">
        <h4>üöë Emergency Response Protocol</h4>
        <p><strong>Call 911 immediately</strong> for aggressive or unresponsive individuals. <strong>Do not attempt restraint</strong> - wait for trained emergency personnel. <strong>Monitor breathing:</strong> PCP can cause respiratory depression. <strong>Cool environment:</strong> Prevent hyperthermia in agitated individuals. <strong>Avoid stimulation:</strong> Loud noises and bright lights can worsen agitation.</p>
      </div>

      <div class="contraindications">
        <h4>üö´ Absolute Contraindications</h4>
        <p><strong>DO NOT USE:</strong> Under any recreational circumstances. History of mental illness, seizure disorders, cardiovascular disease, or previous adverse reactions to dissociatives. <strong>NO SAFE DOSE:</strong> Street preparations make safe use impossible.</p>
      </div>
    </div>

    <div class="profile-section interactions">
      <h3>‚öóÔ∏è Drug Interactions</h3>
      
      <div class="interaction-levels">
        <div class="interaction dangerous">
          <h4>üî¥ LETHAL COMBINATIONS</h4>
          <ul>
            <li><strong>Alcohol:</strong> Multiplicative respiratory depression, coma, death</li>
            <li><strong>Benzodiazepines:</strong> Severe respiratory depression, unpredictable interactions</li>
            <li><strong>Opioids:</strong> Fatal respiratory depression, cardiovascular collapse</li>
            <li><strong>Other dissociatives:</strong> Unpredictable potentiation, prolonged psychosis</li>
            <li><strong>Stimulants:</strong> Dangerous cardiovascular stress, hyperthermia, seizures</li>
          </ul>
        </div>
        
        <div class="interaction risky">
          <h4>üü° Extremely High Risk</h4>
          <ul>
            <li><strong>Antipsychotics:</strong> May reduce some effects but can cause dangerous interactions</li>
            <li><strong>MAOIs:</strong> Risk of hypertensive crisis and serotonin syndrome</li>
            <li><strong>Tricyclic antidepressants:</strong> Enhanced anticholinergic effects, cardiac toxicity</li>
            <li><strong>Anticonvulsants:</strong> May reduce seizure threshold paradoxically</li>
          </ul>
        </div>
        
        <div class="interaction moderate">
          <h4>üü† High Risk</h4>
          <ul>
            <li><strong>Cannabis:</strong> Increased confusion, potential for psychotic episodes</li>
            <li><strong>Psychedelics:</strong> Unpredictable and potentially dangerous experiences</li>
            <li><strong>Nitrous oxide:</strong> Risk of unconsciousness and oxygen deprivation</li>
            <li><strong>Any psychiatric medication:</strong> Unpredictable interactions</li>
          </ul>
        </div>
      </div>
    </div>

    <div class="profile-section legal">
      <h3>‚öñÔ∏è Legal Status</h3>
      <div class="legal-info">
        <div class="legal-jurisdictions">
          <div class="jurisdiction">
            <h4>üá∫üá∏ United States</h4>
            <p><strong>Schedule II</strong> - Controlled substance with high abuse potential. Legal only for veterinary use. Manufacturing and distribution carry severe federal penalties.</p>
          </div>
          <div class="jurisdiction">
            <h4>üá¨üáß United Kingdom</h4>
            <p><strong>Class A</strong> - Most serious drug classification. Possession: up to 7 years imprisonment. Supply: life imprisonment. No medical use authorized.</p>
          </div>
          <div class="jurisdiction">
            <h4>üá®üá¶ Canada</h4>
            <p><strong>Schedule I</strong> - Controlled substance. Possession and trafficking carry serious criminal penalties. No authorized medical use.</p>
          </div>
          <div class="jurisdiction">
            <h4>üá¶üá∫ Australia</h4>
            <p><strong>Schedule 9</strong> - Prohibited substance. Possession and supply illegal except for limited veterinary and research applications.</p>
          </div>
        </div>
        
        <div class="law-enforcement-context">
          <h4>üöî Law Enforcement Response</h4>
          <p><strong>High-priority target:</strong> PCP trafficking and manufacturing heavily pursued due to public safety concerns. <strong>Enhanced penalties:</strong> Many jurisdictions have specific enhanced sentences for PCP-related crimes. <strong>Emergency response:</strong> Police trained specifically for PCP-related incidents due to unpredictable violence.</p>
          
          <h4>üìä Legal Consequences</h4>
          <p><strong>Manufacturing:</strong> Federal sentences of 10+ years for clandestine PCP labs. <strong>Distribution:</strong> Trafficking charges carry mandatory minimum sentences. <strong>Violence while intoxicated:</strong> PCP intoxication not accepted as legal defense for violent crimes. <strong>Public safety priority:</strong> Treated as serious threat to community safety.</p>
        </div>
      </div>
    </div>

    <div class="profile-section history">
      <h3>üìö History & Medical Development</h3>
      
      <div class="history-timeline">
        <div class="history-event">
          <span class="year">1926</span>
          <p>First synthesized by Belgian chemist Victor Maddox at Parke-Davis</p>
        </div>
        <div class="history-event">
          <span class="year">1950s</span>
          <p>Developed as surgical anesthetic under trade name "Sernyl"</p>
        </div>
        <div class="history-event">
          <span class="year">1958</span>
          <p>Human anesthesia trials begin - severe emergence reactions noted</p>
        </div>
        <div class="history-event">
          <span class="year">1965</span>
          <p>Withdrawn from human medical use due to dangerous side effects</p>
        </div>
        <div class="history-event">
          <span class="year">1967</span>
          <p>First illicit street use reported in San Francisco</p>
        </div>
        <div class="history-event">
          <span class="year">1970s-1980s</span>
          <p>Peak of "Angel Dust" epidemic in urban areas</p>
        </div>
        <div class="history-event">
          <span class="year">1978</span>
          <p>Moved to Schedule II due to abuse epidemic</p>
        </div>
        <div class="history-event">
          <span class="year">1990s-present</span>
          <p>Used as research tool for studying schizophrenia and NMDA function</p>
        </div>
      </div>

      <div class="cultural-impact">
        <h4>Urban Legend and Cultural Impact</h4>
        <p>PCP became synonymous with unpredictable violence and "superhuman strength" in popular culture, though these accounts were often exaggerated. The reality - complete anesthesia allowing users to ignore pain and injury - was dangerous enough without embellishment. These myths shaped public perception and law enforcement response to PCP-related incidents.</p>
        
        <h4>Medical Research Legacy</h4>
        <p>Despite its dangers, PCP provided crucial insights into NMDA receptor function and the glutamate system's role in consciousness. It remains an important research tool for understanding schizophrenia, as PCP intoxication closely mimics positive, negative, and cognitive symptoms of the disorder.</p>
      </div>
    </div>

    <div class="profile-section research">
      <h3>üî¨ Current Research & Scientific Applications</h3>
      
      <div class="research-areas">
        <div class="research-item">
          <h4>Schizophrenia Research</h4>
          <p>PCP continues to be used in controlled laboratory settings to study schizophrenia mechanisms. The NMDA receptor hypofunction model of schizophrenia is largely based on PCP's effects, leading to new therapeutic targets.</p>
        </div>
        
        <div class="research-item">
          <h4>NMDA Receptor Function</h4>
          <p>Ongoing research uses PCP to understand normal glutamate neurotransmission and develop new treatments for psychiatric disorders involving NMDA receptor dysfunction.</p>
        </div>
        
        <div class="research-item">
          <h4>Addiction Neuroscience</h4>
          <p>Studies examine how PCP's multi-target activity contributes to addiction, particularly its effects on dopamine systems and compulsive drug-seeking behavior.</p>
        </div>
        
        <div class="research-item">
          <h4>Veterinary Anesthesia</h4>
          <p>Limited research continues into safer veterinary applications, though ketamine has largely replaced PCP for animal procedures due to better safety profile.</p>
        </div>
      </div>

      <div class="discontinued-applications">
        <h4>üè• Discontinued Medical Uses</h4>
        <div class="medical-uses">
          <div class="medical-use">
            <h5>Historical Human Anesthesia (1950s-1965)</h5>
            <ul>
              <li><strong>Surgical anesthesia:</strong> Provided excellent anesthesia but caused severe emergence reactions</li>
              <li><strong>Obstetric anesthesia:</strong> Brief use in childbirth before dangers recognized</li>
              <li><strong>Psychiatric procedures:</strong> Limited use in electroconvulsive therapy</li>
              <li><strong>Withdrawal reasons:</strong> Postoperative delirium, hallucinations, violence</li>
            </ul>
          </div>
          
          <div class="medical-use">
            <h5>Current Veterinary Use (Restricted)</h5>
            <ul>
              <li><strong>Large animal anesthesia:</strong> Limited use in zoos and wildlife management</li>
              <li><strong>Research animals:</strong> Controlled laboratory settings only</li>
              <li><strong>Emergency situations:</strong> When other anesthetics unavailable or ineffective</li>
              <li><strong>Strict protocols:</strong> Requires extensive safety measures and monitoring</li>
            </ul>
          </div>
          
          <div class="medical-use">
            <h5>Research Applications Only</h5>
            <ul>
              <li><strong>NMDA receptor studies:</strong> Understanding glutamate system function</li>
              <li><strong>Schizophrenia models:</strong> Creating animal models of psychotic disorders</li>
              <li><strong>Anesthetic mechanism research:</strong> Understanding consciousness and anesthesia</li>
              <li><strong>Neurotoxicity studies:</strong> Investigating NMDA antagonist brain damage</li>
            </ul>
          </div>
        </div>
      </div>
    </div>

  </div>

  <div class="substance-resources">
    <h3>üìñ Emergency & Crisis Resources</h3>
    <div class="resources-grid">
      <div class="resource-item">
        <h4>Emergency Services</h4>
        <ul>
          <li><a href="tel:911">911 Emergency Services</a> - Immediate medical/police response</li>
          <li><a href="https://www.poison.org/">Poison Control</a> - 24/7 poisoning emergency guidance</li>
          <li><a href="https://www.samhsa.gov/find-help/national-helpline">SAMHSA Helpline</a> - Crisis intervention and treatment referral</li>
        </ul>
      </div>
      
      <div class="resource-item">
        <h4>Mental Health Crisis</h4>
        <ul>
          <li><a href="https://www.nami.org/">NAMI</a> - Mental health crisis support and education</li>
          <li><a href="https://suicidepreventionlifeline.org/">Crisis Lifeline</a> - 24/7 mental health crisis support</li>
          <li><a href="https://www.crisistextline.org/">Crisis Text Line</a> - Text-based crisis intervention</li>
        </ul>
      </div>
      
      <div class="resource-item">
        <h4>Addiction Treatment</h4>
        <ul>
          <li><a href="https://www.samhsa.gov/find-treatment">Treatment Locator</a> - Find addiction treatment services</li>
          <li><a href="https://www.na.org/">Narcotics Anonymous</a> - Peer support recovery meetings</li>
          <li><a href="https://www.smartrecovery.org/">SMART Recovery</a> - Science-based addiction recovery</li>
        </ul>
      </div>
    </div>
  </div>

  <div class="medical-context">
    <h3>üè• Medical Context & Public Health Impact</h3>
    <div class="medical-info-grid">
      <div class="medical-info-item">
        <h4>Anesthetic Development Failure</h4>
        <p>PCP represents one of the most dramatic failures in anesthetic development - a drug with excellent anesthetic properties rendered unusable by catastrophic side effects. Its withdrawal from human medicine led to the development of safer dissociative anesthetics like ketamine.</p>
      </div>
      
      <div class="medical-info-item">
        <h4>Public Health Crisis Legacy</h4>
        <p>The PCP epidemic of the 1970s-1980s fundamentally changed emergency medicine protocols and law enforcement training. Emergency departments developed specific procedures for PCP intoxication, recognizing it as a unique and dangerous form of drug emergency.</p>
      </div>
      
      <div class="medical-info-item">
        <h4>Research Tool Paradox</h4>
        <p>Despite being too dangerous for human therapeutic use, PCP remains invaluable for neuroscience research. Its ability to model schizophrenia symptoms has led to major breakthroughs in understanding psychiatric disorders and developing new treatments.</p>
      </div>
    </div>
  </div>

</div>
    </main>
     <div class="footer-divider"></div>
<footer class="site-footer">
  
</footer>




<footer class="site-footer">
  
  </svg>
    <img src="/assets/logo.svg" alt="My Logo" class="logo">
     <p>¬© 2025 Uwaniumnya. Highly Illegal.</p>
  </footer>

  

    <!-- Search Scripts -->
    <script src="/Dyo-s-Dubious-Domain/js/lunr.min.js"></script>
    <script src="/Dyo-s-Dubious-Domain/assets/js/search.js"></script>
    <script src="/Dyo-s-Dubious-Domain/assets/js/substance-integration.js"></script>
    
    <!-- Only load profile.js on profile page -->
    
</body>
</html>